Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer

Introduction: The integration of diagnostic testing for the presence of a molecular target is of interest to predict successful targeted radionuclide therapy (TRNT). This so-called ‘theranostic’ approach aims to improve personalized treatment based on the molecular characteristics of cancer cells. M...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Huyvetter, Matthias, Xavier, Catarina, Caveliers, Vicky, Lahoutte, Tony, Muyldermans, Serge, Devoogdt, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245996/
https://www.ncbi.nlm.nih.gov/pubmed/25035968
http://dx.doi.org/10.1517/17425247.2014.941803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245996/
https://www.ncbi.nlm.nih.gov/pubmed/25035968
http://dx.doi.org/10.1517/17425247.2014.941803

Ejemplares similares